Supplementary Figure 2. Targeted sequencing of BM fragments to identify somatic mutations. (A) Somatic mutations detected in 24 BM fragments selected for targeted sequencing, plotted at their location in the original sectioned specimen, color-coded by detected mutations and labeled with VAF. (B) Correlation of somatic mutations detected by sequencing and confirmed by ddPCR for JAK2 V617F (R2=0.99). (C) Correlation of somatic mutations detected by sequencing and confirmed by ddPCR for TET2 L1081* (R2=0.35).
No takes yet. Share an insight, caveat, or question.
Young et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: